Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological effects of RAD001 on invasive breast cancer
2004-001712-31Phase 2Completed
- Sponsor
- NHS Lothian
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in breast cancer, sponsored by NHS Lothian. Primary endpoints: Changes in RAD markers, PAK/AKT immunohistochemistry and 4 more. Started Jul 2005; status: completed.
02
Drugs
everolimus
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-001712-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001712-31.